Rapid bioavailability test Promonitor®

for antigensbiologicalELISA

The Promonitor family of tests measures both drug levels and anti-drug antibody levels with validated ELISA assays to complement biological therapies for drug monitoring. Testing for drug bioavailability and immunogenicity: IFX, Anti-IFX, ADL, Anti-ADL, RTX, Anti-RTX, ETN, Anti-ETN, GLM, Anti-GLM, VDZ, Anti-VDZ, UTK, Anti-UTK. Optimize Therapy Refine treatment of chronic inflammatory diseases with a personalized approach to therapy with biologics. Individualized treatment for every patient, enabling a personalized approach to therapy with biologics Early information about reduced drug efficacy - Promonitor provides an early warning if the treatment regime may require modification Cost Effective Reduce the use of ineffective treatment strategies, allowing a more efficient use of available resources. Effectively manage resources with the information provided by Promonitor Easy to Use Quickly generate results with ELISA-based tests and readily available equipment. Quick procedure - 4 simple steps Microplate precoated and ready-to-use reagents Easy data interpretation Flexible Expand lab operations and workflow with multiple tests and configurations. Removable strips allow multiple configurations Test both drug levels and anti-drug antibody levels Manual or automated mode High Quality Rely on results with a high quality product. High specificity and sensitivity Supported by a large number of peer-reviewed articles